Novo Nordisk expects to follow up on terrific 2023 with double-digit growth next year
Although Novo Nordisk has basically achieved two of its major 2025 targets after the year’s first nine months, the company expects continued growth next year.
With the publication of Thursday’s financial report for the first nine months of the year, Novo Nordisk can more or less check off two of the company’s major strategic goals for 2025. And that’s more than a year ahead of schedule.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
